Toxicological Sciences 72, 185-187 (2003)
Copyright © 2003 by the Society of Toxicology
TOXICOLOGICAL HIGHLIGHT |
From Anticholinesterase Toxicity to Alzheimers Disease: Important Interactions of Cholinergic and NMDA Receptor Systems
Safety Pharmacology, Wyeth Research, 641 Ridge Road, Chazy, NY 12921
For correspondence via fax: (518) 846-6383. E-mail: popkej{at}wyeth.com.
ABSTRACT
The article highlighted in this issue is "Dizocilpine Improves Beneficial Effects of Cholinergic Antagonists in Anticholinesterase-Treated Mice," by Andrzej Dekundy, Rafal M. Kaminski, and Waldemar A. Turski (pp. 289295). It explores the relationship between cholinergic and N-methyl-D-aspartate (NMDA) receptors as mediators of anticholinesterase toxicity. The following review summarizes these findings and discusses their broader implications for central nervous system pharmacology. Alzheimers disease is discussed as an example of how knowledge of the interactions between NMDA and cholinergic receptors may lead to a better understanding of human disease.